MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-12-2026
Utah Medical Products Operating Cash Flow 2011-2026 | UTMD
Annual Operating Cash Flow Utah Medical Products
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.7 M | 14.8 M | 22.3 M | 21.1 M | 21.2 M | 20.1 M | 17.1 M | 16.8 M | 16.9 M | 14.5 M | 13.8 M | 15.4 M | 12.3 M | 13.6 M | 11.4 M | 7.16 M | 7.23 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.3 M | 7.16 M | 15.3 M |
Quarterly Operating Cash Flow Utah Medical Products
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.11 M | - | - | 4.46 M | - | - | - | 5.28 M | - | - | - | 6.92 M | - | 15.5 M | 9.88 M | 5.05 M | - | 16.2 M | 10.2 M | 5.53 M | - | 14.4 M | 9.35 M | 5.67 M | - | 11.4 M | 5.04 M | 3.36 M | - | 12.4 M | 7.75 M | 3.77 M | - | 12.3 M | 7.74 M | 4.31 M | - | 11.1 M | 7.76 M | 4.15 M | - | 9.9 M | 5.73 M | 2.24 M | - | 10.9 M | 5.76 M | 1.92 M | - | 9.06 M | 5.04 M | 2.72 M | - | 10.5 M | 6.54 M | 3.43 M | - | 7.86 M | 4.45 M | 2.76 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.2 M | 1.92 M | 7.28 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
796 M | $ 62.02 | 2.78 % | $ 12.3 B | USA |
 |
Glaukos Corporation
GKOS
|
-14.8 M | $ 121.69 | 7.24 % | $ 6.96 B | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 418.82 | 2.83 % | $ 149 B | USA |
 |
Alcon
ALC
|
1.34 B | $ 66.58 | 3.67 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
180 M | $ 134.93 | 3.38 % | $ 3.32 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.14 | 5.61 % | $ 191 M | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 107.35 | 2.67 % | $ 3.44 B | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | - | - | $ 2.12 B | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.9 | 0.07 % | $ 9.54 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | - | - | $ 89.7 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.43 | 11.28 % | $ 35.3 M | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 9.94 | 0.81 % | $ 84.3 K | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 22.87 | 2.1 % | $ 3.84 B | USA |
 |
Haemonetics Corporation
HAE
|
293 M | $ 69.85 | 6.03 % | $ 3.3 B | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
STERIS plc
STE
|
1.34 B | $ 212.24 | 0.98 % | $ 20.8 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 29.86 | 5.66 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
24.4 M | $ 9.12 | 1.0 % | $ 188 M | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 63.04 | 3.94 % | $ 3.73 B | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 317.32 | 0.32 % | $ 22.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 9.88 | 2.49 % | $ 1.97 B | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 26.94 | 7.8 % | $ 1.82 B | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.66 | 0.41 % | $ 19.8 M | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 67.0 | 2.81 % | $ 220 M | USA |
 |
Predictive Oncology
POAI
|
-13.2 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
20.1 M | - | - | $ 1.29 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.88 | 2.17 % | $ 171 M | USA |
 |
Baxter International
BAX
|
845 M | $ 19.35 | 4.31 % | $ 9.93 B | USA |
 |
ResMed
RMD
|
351 M | $ 194.32 | 4.2 % | $ 28.4 B | USA |
 |
AtriCure
ATRC
|
57.3 M | - | - | $ 1.3 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | - | - | $ 288 M | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 12.03 | 7.41 % | $ 491 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 149.56 | 2.73 % | $ 43 B | USA |
 |
Nephros
NEPH
|
1.64 M | $ 3.59 | -1.37 % | $ 38.1 M | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 4.17 | 5.57 % | $ 306 M | USA |
 |
Repligen Corporation
RGEN
|
117 M | $ 126.55 | 3.96 % | $ 7.12 M | USA |